LAB 8-K 2026-10-05
STANDARD BIOTOOLS INC. (LAB) 8-K dated 2026-10-05 — accession 0001140361-26-038624.
STANDARD BIOTOOLS INC. (LAB) is a medical devices company listed on NASDAQ.
STANDARD BIOTOOLS INC. filed a 8-K on 2026-10-05. Accession 0001140361-26-038624.
This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported LAB revenue for 2025-12-31 was $85.3M. Net income was -$74.9M. Revenue was down 51.1% from 2024-12-31 to 2025-12-31. LAB currently screens at market cap $317.1M.
Not investment advice. The LAB SEC hub lists recent forms. The stock page is the research view.